SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as retail investors draw comparisons to the 2021 short squeeze, with some hoping it will mirror the recent volatility in $BYND. Community members discuss call options, potential buybacks, and the possibility of a gamma squeeze. Despite the positive price action, some remain skeptical, citing weak fundamentals and high volatility.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer's stock is trending due to a revised revenue outlook, citing design win upgrades impacting delivery schedules and shifting some revenue to the next quarter. Despite reiterating a strong fiscal year forecast, the community is actively debating the impact of the news, management's credibility, and potential trading strategies given the volatility. Some investors express frustration with the company's leadership and consistency in meeting expectations, while others view the dip as a buying opportunity amidst robust AI demand.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending as it joins the S&P 100, sparking community discussion about the company finally breaking the $100 mark. Bullish sentiment is fueled by strong financials, autonomous vehicle developments, and a potential for further gains, although some traders express frustration with past price action. Many are closely watching if Uber can maintain momentum and solidify its position.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending as investors anticipate the upcoming GTC conference, where new products and partnerships are expected to be revealed, possibly driving the stock toward $190. Bullish sentiment is fueled by optimism surrounding potential deals and positive economic data, while some traders are wary of potential pullbacks and China-related headwinds. The community is actively discussing potential price movements and technical analysis, with strong opinions on both bullish and bearish scenarios.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending due to a new partnership with Anthropic focused on AI-powered software development, sparking excitement about IBM's growing presence in the AI space. Community members highlight IBM's existing strength in quantum computing and hybrid cloud as additional reasons for optimism. Despite positive developments, some caution is present, with discussion around valuations and whether IBM can maintain its competitive edge.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum ($QBTS) is trending amid speculation that the Trump administration might take an equity stake in quantum computing firms, fueling significant community discussion and trading volume. Despite some contradictory reports and denials of ongoing negotiations, chatter persists around the potential for government investment to boost the sector and counter China's quantum initiatives. Traders are actively debating the validity of news sources and the potential impact on the stock's future.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is trending as investors discuss its strategic partnership with Palantir to enhance enterprise AI capabilities and its potential role in the growing AI sector, particularly regarding data centers and fiber optic infrastructure. Community members are also anticipating upcoming earnings and speculating on potential acquisitions. The broader discussion revolves around Lumen's transformation and its position in the evolving tech landscape.

Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded by Raju S. Mohan on November 21, 2018 and is headquartered in San Diego, CA.

Ventyx Biosciences Inc

Ventyx Biosciences is trending following positive Phase 2 trial results for its Parkinson's drug, showing safety and target engagement. The community is buzzing about potential analyst upgrades and buyout scenarios, particularly by Sanofi given their existing relationship. Discussions also involve the drug's broader applicability and market potential beyond Parkinson's.

Bleichroeder Acquisition Corp. I is a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Andrew Stephen Gundlach and Michel Combes on June 24, 2024 and is headquartered in New York, NY.

Bleichroeder Acquisition Corp. I - Ordinary Shares - Class A

Bleichroeder Acquisition Corp I

Bleichroeder Acquisition Corp I (BACQ) is trending due to increased interest following bullish sentiment from Citron Research, highlighting the company's merger with Merlin Labs, an AI autonomous flight technology firm, and existing government contracts. The community is actively discussing the potential for significant gains, particularly focusing on the undervalued rights and the company's partnerships within the aerospace and defense sectors. Some are drawing comparisons to other AI-related SPACs and anticipating a substantial price increase.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the community debates the stock's valuation and future potential, with discussions around the company's AI and robotics initiatives. Despite mixed earnings, the stock has seen a significant intraday recovery, leading to speculation about short squeezes and market manipulation. Some traders are closely watching the $450 level as a key indicator for further price movement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The new customer account represents one of INBS's most significant UK commercial deployments to date, the company said.</li><li>Intelligent Bio’s Intelligent Fingerprinting Drug Screening System uses fingerprint sweat analysis to identify recent use of drugs commonly found in the workplace.</li><li>Intelligent Bio is currently seeking FDA clearance to enter the U.S. workplace testing market beyond the Forensic Use Only category.</li></ul>Shares of Intelligent Bio Solutions (INBS) jumped over 1% on Thursday morning after the company announced that it has secured a major new contract with one of UK's largest industrial service providers for its drug testing technology.The unnamed company has operations across the energy, defense, nuclear, and industrial sectors and employs over 30,000 people globally, Intelligent Bio said. In the UK and Ireland alone, the company employs approximately 3,000 staff across multiple sites, it added.<h2 class="st-heading-2">Contract Details</h2>The new customer account represents one of INBS's most significant UK commercial deployments to date, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/10/23/3172035/0/en/Intelligent-Bio-Solutions-Secures-Major-UK-Contract-with-Multinational-Industrial-Service-Provider.html">said.</a> The medical technology stated that the adoption of its drug testing technology is part of the customer’s initiative to enhance workforce compliance and intended to replace the existing testing process based on urine collection and third-party testing.Intelligent Bio’s Intelligent Fingerprinting Drug Screening System is expected to reduce downtime, increase productivity, and deliver rapid results at point of testing through fingerprint sweat analysis. The technology screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. It provides results in under ten minutes.<blockquote>“Securing this account highlights the expanding market confidence in our technology and its growing role in transforming drug testing across some of the world's largest industrial operators.” -Harry Simeonidis, CEO, Intelligent Bio Solutions</blockquote><h2 class="st-heading-2"> Plans Ahead</h2>Intelligent Bio is currently seeking FDA clearance to enter the U.S. workplace testing market beyond the Forensic Use Only category.The category "Forensic Use Only" applies to testing devices that have not been cleared by the U.S. Food and Drug Administration (FDA) for clinical or over-the-counter use. Instead, these products are intended exclusively for use by law enforcement.<h2 class="st-heading-2">What Are Stocktwits Users Saying?</h2>On Stocktwits, retail sentiment around INBS jumped from ‘bearish’ to ‘bullish’ territory over the past 24 hours, while message volume jumped from ‘low’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:584/62;" src="data:image/png;base64,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" width="584" height="62" alt="INBS's Sentiment Meter and Message Volume as of 11:25 a.m. ET on Oct. 23, 2025 | Source: Stocktwits"><figcaption>INBS's Sentiment Meter and Message Volume as of 11:25 a.m. ET on Oct. 23, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user said that they are bullish on the long term outlook for the stock.<stembedurl>https://stocktwits.com/Chrisssss1/message/633407341</stembedurl>Another applauded the contract, terming it a sign of demand.<stembedurl>https://stocktwits.com/louter_genieten/message/633398481</stembedurl><a href="https://stocktwits.com/symbol/INBS">INBS stock</a> is down by 28% this year and by about 31% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/harmony-biosciences-raises-full-year-revenue-guidance-ahead-of-earnings/cLG4ilnR3rG">Harmony Biosciences Raises Full-Year Revenue Guidance Ahead Of Earnings: Why Are Wakix Franchise Numbers Crucial?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

Intelligent Bio Solutions Stock Rises On New Contract For Drug Testing Technology

The new customer account represents one of INBS's most significant UK commercial deployments to date, the company said.

Equity

INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach

Shares of Intelligent Bio Solutions Inc. (INBS) traded 12% higher on Wednesday after the medical technology company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/06/11/3097535/0/en/Intelligent-Bio-Solutions-Expands-U-S-Forensic-Market-Presence-Seeks-FDA-Clearance-for-Breakthrough-Fingerprint-Drug-Testing.html">announced</a> a partnership with Texas-based drug and alcohol screening services provider SMARTOX.Intelligent Bio is actively pursuing FDA clearance for its opiate test system for codeine, aiming to enable expansion into broader U.S. markets this year, including workplace drug testing, utilizing its fingerprint-sweat-based testing technology.The technology aims to eliminate more invasive testing solutions that require urine or saliva collection.Doug Heath, Vice President of Global Sales at Intelligent Bio Solutions, stated that the company has partnered with SMARTOX to expand access to its fingerprint drug screening system across key forensic settings, including criminal justice.SMARTOX supports clients across corrections, drug courts, rehabilitation centres, and other forensic environments. It has deployed over 50 Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests.Intelligent Bio’s clientele outside the U.S., meanwhile, includes employers across safety-critical industries, such as construction, manufacturing, and engineering, as well as transport and logistics firms, mining companies, drug treatment organizations, and coroners.On Stocktwits, retail sentiment around Intelligent Bio Solutions jumped from ‘bearish’ to ‘bullish’ territory over the past 24 hours while message volume remained at ‘high’ levels.<figure class="image"><img style="aspect-ratio:628/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_11_at_12_29_36_PM_png_32ed437694.webp" alt="INBS's Sentiment Meter and Message Volume as of 12:25 p.m. ET on Jun 11, 2025 | Source: Stocktwits" width="628" height="64"><figcaption>INBS's Sentiment Meter and Message Volume as of 12:25 p.m. ET on Jun 11, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed optimism that the stock could reach as high as $2.60.<stembedurl>https://stocktwits.com/SoldierOfGod/message/617565072</stembedurl>Another cheered a potential FDA approval.<stembedurl>https://stocktwits.com/Prostar/message/617557745</stembedurl><a href="https://stocktwits.com/symbol/INBS">INBS stock</a> is up by about 45% this year and approximately 4% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/fda-completes-inspection-of-capricor-manufacturing-facility-for-deramiocel-approval/chlaD5GRbCD">FDA Completes Inspection of Capricor Therapeutics Manufacturing Facility For Deramiocel Approval: Retail Sees ‘Unimaginable Potential’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A prison officer carries out a test for illegal substances such as drugs at Tegel Prison. Photo: Fabian Sommer/dpa (Photo by Fabian Sommer/picture alliance via Getty Images)

Intelligent Bio Rises On Partnership With Smartox To Expand US Market Presence: Retail Hopes The Stock To Hit $2.6

Intelligent Bio is actively pursuing FDA clearance for its opiate test system for codeine, utilizing its fingerprint sweat-based testing technology.

Intelligent Bio Solutions Hits 1,000 Drug Screening Installations

An update from Intelligent Bio Solutions (INBS) is now available. Intelligent Bio Solutions Inc. has announced a significant achievement in their p...

Intelligent Bio Solutions Restructures Board after Loss

The latest announcement is out from Intelligent Bio Solutions (INBS). Intelligent Bio Solutions Inc. mourns the loss of Lawrence Fisher, a revered...

Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC

NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive...

Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive...

Intelligent Bio Solutions prices $10.1M at-the-market offering at $4.55 per shha

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive...

Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now

MIAMI, March 06, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 68th Emerging Growth Conference on March 6 & 7, 2024. The...

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

INBS
Intelligent Bio Solutions Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest INBS News

INBSIntelligent Bio Solutions Inc